Suppr超能文献

体内静息CD4+ T细胞中人类免疫缺陷病毒1型蛋白酶和逆转录酶区域的G→A超突变。

G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.

作者信息

Kieffer Tara L, Kwon Patty, Nettles Richard E, Han Yefei, Ray Stuart C, Siliciano Robert F

机构信息

Department of Medicine, Johns Hopkins University School of Medicine, 879 Broadway Research Bldg., 733 N. Broadway, Baltimore, MD 21205, USA.

出版信息

J Virol. 2005 Feb;79(3):1975-80. doi: 10.1128/JVI.79.3.1975-1980.2005.

Abstract

In vitro studies have shown that the host cytidine deaminase APOBEC3G causes lethal hypermutation in human immunodeficiency virus type 1 reverse transcripts unless its incorporation into virions is blocked by Vif. By examining stably archived sequences in resting CD4+ T cells, we show that hypermutation occurs in most if not all infected individuals. Hypermutated sequences comprised >9% of archived species in resting CD4+ T cells but were not found in plasma virus. Mutations occurred in predicted contexts, with notable hotspots. Thus, defects in Vif function in vivo give rise to hypermutated viral genomes that can be integrated but do not produce progeny viruses.

摘要

体外研究表明,宿主胞苷脱氨酶APOBEC3G会导致1型人类免疫缺陷病毒逆转录产物发生致死性超突变,除非其掺入病毒体的过程被Vif阻断。通过检查静息CD4+ T细胞中稳定存档的序列,我们发现,在大多数(如果不是全部)受感染个体中都会发生超突变。超突变序列在静息CD4+ T细胞的存档病毒种类中占比超过9%,但在血浆病毒中未发现。突变发生在预测的背景下,有明显的热点。因此,体内Vif功能缺陷会产生可整合但不产生子代病毒的超突变病毒基因组。

相似文献

4
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
Nature. 2005 May 5;435(7038):108-14. doi: 10.1038/nature03493. Epub 2005 Apr 13.

引用本文的文献

1
HIV-1 Vif global diversity and possible APOBEC-mediated response since 1980.
Virus Evol. 2024 Dec 12;11(1):veae108. doi: 10.1093/ve/veae108. eCollection 2025.
6
Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G.
Mol Ther Nucleic Acids. 2023 Aug 11;33:794-809. doi: 10.1016/j.omtn.2023.08.007. eCollection 2023 Sep 12.
8
Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2.
J Mol Biol. 2022 Jan 30;434(2):167355. doi: 10.1016/j.jmb.2021.167355. Epub 2021 Nov 10.
9
Potential Utilization of APOBEC3-Mediated Mutagenesis for an HIV-1 Functional Cure.
Front Microbiol. 2021 Jun 15;12:686357. doi: 10.3389/fmicb.2021.686357. eCollection 2021.
10
HIV-1 Persistence in Children during Suppressive ART.
Viruses. 2021 Jun 12;13(6):1134. doi: 10.3390/v13061134.

本文引用的文献

1
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.
Curr Biol. 2004 Aug 10;14(15):1385-91. doi: 10.1016/j.cub.2004.06.050.
3
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.
EMBO J. 2004 Jun 16;23(12):2451-8. doi: 10.1038/sj.emboj.7600246. Epub 2004 May 20.
4
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.
Nat Struct Mol Biol. 2004 May;11(5):435-42. doi: 10.1038/nsmb758. Epub 2004 Apr 18.
6
A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5652-7. doi: 10.1073/pnas.0400830101. Epub 2004 Mar 30.
8
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).
Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3927-32. doi: 10.1073/pnas.0307132101. Epub 2004 Feb 20.
9
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
Nat Med. 2003 Nov;9(11):1398-403. doi: 10.1038/nm946. Epub 2003 Oct 5.
10
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
Nat Med. 2003 Nov;9(11):1404-7. doi: 10.1038/nm945. Epub 2003 Oct 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验